Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing. - Wikidata - wikimedia - TriplyDB

Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.

Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.

http://www.wikidata.org/entity/Q39227219

about

Proteoglycan form and function: A comprehensive nomenclature of proteoglycans The role of perlecan and endorepellin in the control of tumor angiogenesis and endothelial cell autophagy Decoding the Matrix: Instructive Roles of Proteoglycan Receptors Vascular Endothelial Growth Factor Release Following Electrical Stimulation in Human Subjects Can we produce heparin/heparan sulfate biomimetics using "mother-nature" as the gold standard?A current view of perlecan in physiology and pathology: A mosaic of functions.Endorepellin evokes autophagy in endothelial cells Transcriptional activation by NFκB increases perlecan/HSPG2 expression in the desmoplastic prostate tumor microenvironment IL-33/ST2 axis promotes mast cell survival via BCLXL.Proteoglycans in Normal and Healing Skin.Complement deficiency promotes cutaneous wound healing in mice.Effects and mechanisms of a microcurrent dressing on skin wound healing: a review The role of Lin28b in myeloid and mast cell differentiation and mast cell malignancy Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers PKCδ inhibition normalizes the wound-healing capacity of diabetic human fibroblasts.Mast Cells Produce a Unique Chondroitin Sulfate Epitope The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling.Recombinant production of proteoglycans and their bioactive domains.Endorepellin-evoked Autophagy Contributes to Angiostasis.Antitumoral effects of γCdcPLI, a PLA2 inhibitor from Crotalus durissus collilineatus via PI3K/Akt pathway on MDA-MB-231 breast cancer cell.Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection.Recombinant Domain V of Human Perlecan Is a Bioactive Vascular Proteoglycan.Optimization of bioengineered heparin/heparan sulfate production for therapeutic applications.Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation.Cell surface chondroitin sulphate proteoglycan 4 (CSPG4) binds to the basement membrane heparan sulphate proteoglycan, perlecan, and is involved in cell adhesion.

P2860

Q21710680-F11EAF31-BE8C-41E0-8EA2-DDA4D437769D Q26800258-07CE911F-5415-4F7E-980B-D0875B7DD8E1 Q26801397-9E891524-0DD3-461F-8640-A28FA45AA180 Q27002452-AD7817C6-C78F-4806-A9B6-5EFD5F8A7E5F Q27021503-86CE4B49-FF9E-4A2C-B551-9ABCA08BEC88 Q30392738-F96FE32B-D9C2-4436-AD29-54C039DF013B Q33718473-9CB1C64F-8391-4C64-B1C2-F86BB587BD10 Q33882116-6698B81C-9095-4B54-BAAA-98616FC4D9FC Q33925929-471771C7-E524-4D76-BE28-33987C6CD05A Q34467680-1D796E8F-A19A-4DA2-8943-A669FBF5CFFE Q34980307-F4BD9A1A-0D66-4B03-B580-879D186D3751 Q35633907-9A21111A-C057-414A-AD45-72E4A17D86AD Q35685193-4C920C0B-CED1-4160-8AC3-5E23BA327B31 Q36578668-11EFF804-A5AE-41BB-A38A-6D85497939FD Q36618518-95376424-9073-48E5-8B56-04320B00C401 Q36742597-252F238B-E913-4243-A914-9861732F32FE Q37271260-E3636ADB-66D4-4445-9031-8F6D1F76C71E Q38082553-B3F113E3-B0BC-4046-89F9-7EE4FEA6F7F2 Q41049426-634E2CEF-65C6-4A46-884C-A0C4B065CF28 Q41203587-12B9DF2B-AC46-49CA-B812-12BA9D4C9A03 Q47719302-CFDFC11F-E5A5-436A-B4EA-7DBA81896AA5 Q47748239-74206CB8-C837-4C47-A8E2-8B329CD862D9 Q48295996-E962C64C-D05D-4572-BF18-88606D7AEA09 Q51032187-2F435931-F01A-4739-89EA-0678CC95B4FB Q52375995-8CC97668-9792-4380-82B0-F5E4BE7B1691

P2860

Mast cells produce novel shorter forms of perlecan that contain functional endorepellin: a role in angiogenesis and wound healing.

http://www.wikidata.org/entity/Q39227219

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Mast cells produce novel short ...... ngiogenesis and wound healing.

@en

Mast cells produce novel short ...... ngiogenesis and wound healing.

@nl

type

label

Mast cells produce novel short ...... ngiogenesis and wound healing.

@en

Mast cells produce novel short ...... ngiogenesis and wound healing.

@nl

prefLabel

Mast cells produce novel short ...... ngiogenesis and wound healing.

@en

Mast cells produce novel short ...... ngiogenesis and wound healing.

@nl

P1433

Q39227219-D74F5E57-6BF9-4766-BD73-1AA76E452FAF

P1476

Q39227219-9965F0EA-95E7-4B8F-AEAC-954C6F788B5F

P2093

Q39227219-49C49AB7-D665-4349-8818-48573DAA8FBE

Q39227219-8D916CED-996C-443C-A5C8-BDD2CE9787CB

Q39227219-B58A9F87-4F79-45CE-8D6D-CCFDBA05914D

Q39227219-D942B6DE-CAB1-4B7A-A91B-6CC8C214571A

Q39227219-FAB7FD0B-0212-4220-BECF-32A58E088847

P2860

Q39227219-00FECB59-CE63-48B2-BC73-C63C67B879DF

Q39227219-025FA90F-751D-4451-97E6-9028EE8EB5A3

Q39227219-05336CD2-6819-460A-B948-22218DA4635F

Q39227219-0663F2E8-C927-47DD-B180-190692CAECDC

Q39227219-08FDD7B4-5618-42A8-A24B-51D18F137FDE

Q39227219-0C48C66C-7517-4A64-8F40-C2F2754E89AE

Q39227219-121826CF-8027-4F91-AAA7-8D74406D5F13

Q39227219-15663F0E-0FBE-479C-B798-EA6D03209F3B

Q39227219-1BFC333A-115D-43EE-8404-1A84DFA22C3F

Q39227219-2C6D40FB-2FE6-4907-AE6C-19C6B6A97423

P304

Q39227219-F9400C4B-5DC9-49DD-98C3-0147DBCF31A9

P31

Q39227219-B5A5D964-E69C-419F-A99B-827206CF2EC4

P356

Q39227219-90E0DF60-1B84-4BBE-B511-C8F8C26395DC

P407

Q39227219-9615B6C9-7F3C-4ACD-925C-5A303176E916

P433

Q39227219-2AEE7327-AC17-43B7-816C-33F9C09FBC18

P478

Q39227219-7489CA6D-F4C9-40A6-B242-C6EC4C65CF21

P50

Q39227219-1F2F21FA-2A87-4726-B3DF-7E124055AD52

Q39227219-47D16140-8860-4511-BB72-A99A3CC4A121

Q39227219-E3926A98-9635-43A6-AA4F-3F0EE15FBCD0

Q39227219-E7FB2954-0E89-4022-BAC2-5C709826B007

P577

Q39227219-9DC6D29B-E052-4C36-B4AF-C103689DF035

P698

Q39227219-A3910391-67B6-41C9-A1AE-BAC8BA08E077

P921

Q39227219-B3170487-072A-447C-AD72-E89093FD3245

P932

Q39227219-94DDE852-B201-456B-BDF0-07011DCB04C5

P356

JBC.M112.387811

P1433

Journal of Biological Chemistry

P1476

Mast cells produce novel short ...... angiogenesis and wound healing

@en

P2093

Bill Cheng

http://www.w3.org/2001/XMLSchema#string

Hatem Alkhouri

http://www.w3.org/2001/XMLSchema#string

J Margaret Hughes

http://www.w3.org/2001/XMLSchema#string

Moonsun Jung

http://www.w3.org/2001/XMLSchema#string

Simon J McCarthy

http://www.w3.org/2001/XMLSchema#string

P2860

Serglycin constitutively secreted by myeloma plasma cells is a potent inhibitor of bone mineralization in vitro

Heparanase cleavage of perlecan heparan sulfate modulates FGF10 activity during ex vivo submandibular gland branching morphogenesis

Endorepellin, the angiostatic module of perlecan, interacts with both the α2β1 integrin and vascular endothelial growth factor receptor 2 (VEGFR2): a dual receptor antagonism

Analysis of smu-1, a gene that regulates the alternative splicing of unc-52 pre-mRNA in Caenorhabditis elegans

Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts

The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7

Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan

Changes in perlecan during chondrocyte differentiation in the fetal bovine rib growth plate

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases

Isolation and characterization of a cDNA that encodes the peptide core of the secretory granule proteoglycan of human promyelocytic leukemia HL-60 cells

P304

3289-3304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M112.387811

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

288

http://www.w3.org/2001/XMLSchema#string

P50

Renato V. Iozzo

P577

2012-12-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23235151

http://www.w3.org/2001/XMLSchema#string

P921

P932

3561549

http://www.w3.org/2001/XMLSchema#string